Nucleo Bio
Healthcare Services · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
60 Byron Ave, Yonkers, New York, 10704, ...Website
www.nucleobio.netRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Nucleo Bio
NucleoBio specializes in early and precise prostate cancer detection through its innovative product, Prostac, a non-invasive molecular blood test. This test is designed to provide men, particularly those at higher risk for prostate cancer, with accurate results that can replace traditional PSA tests. Prostac not only detects the presence of prostate cancer but also assesses its aggressiveness and helps categorize the risk level, aiding physicians in treatment decisions. By offering a straightforward testing process, NucleoBio aims to alleviate the stress of uncertain diagnoses and empower men to take control of their health.Explore more
Nucleo Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nucleo Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Nucleo Bio has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Nucleo Bio has new funding data
Click to see if Nucleo Bio had a recent Job posting/layoffs
Product Launch: Get notified when Nucleo Bio launches new products
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Nucleo Bio
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Nucleo Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Nucleo Bio recently announced quarterly report
Check out if Nucleo Bio is spiking on competitors!
Recommended Actions
Find VP level buyers at Nucleo Bio
Find 3 more new buyers
Compare Similar Companies to Nucleo Bio
Compare insights from companies similar to Nucleo Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Nucleo Bio is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Nucleo Bio is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Nucleo Bio.
Nucleo Bio Tech Stack
A closer look at the technologies used by Nucleo Bio
See more technologies
Nucleo Bio News & Media
New Cancer Test Improves Diagnosis of Prostate Cancer, Product Significantly Improves Diagnostics for Men's Health Care
NEW YORK, May 4, 2018 /PRNewswire/ -- Recognizing that prostate cancer in men is misdiagnosed, NucleoBio Inc.™ is developing a new product, Prostac©, that will accurately reveal results of a prostate cancer screening. Currently, there is no test that differentiates between indolent and...
Read more news
Top Healthcare Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nucleo Bio
Sign Up For FreeTo access detailed company insights
NucleoBio specializes in early and precise prostate cancer detection through its innovative product, Prostac, a non-invasive molecular blood test. This test is designed to provide men, particularly those at higher risk for prostate cancer, with accurate results that can replace traditional PSA tests. Prostac not only detects the presence of prostat... Read More
